Le Lézard
Classified in: Business
Subject: ATY

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bolt Biotherapeutics, Inc. - BOLT


NEW YORK, June 24, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Bolt Biotherapeutics, Inc. ("Bolt" or the "Company") (NASDAQ: BOLT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.

The investigation concerns whether Bolt and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here for information about joining the class action] 

On May 14, 2024, Bolt announced in a press release that the Company would "cease further development of trastuzumab imbotolimod (BDC-1001)," Bolt's lead asset, "and reduce workforce by approximately 50%." Following Bolt's announcement, multiple analysts downgraded the Company's stock. 

On this news, Bolt's stock price fell $00.49 per share, or more than 37.12%, to close at $00.83 per share on May 15, 2024.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.   

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP


These press releases may also interest you

at 06:00
UnitedHealth Group reported second quarter 2024 results reflecting broad-based growth at Optum and UnitedHealthcare. "The diversified, durable growth across UnitedHealth Group stems from our colleagues' commitment to ensuring high-quality,...

at 05:25
Previously the Head of Commodity Derivatives (Americas) at BNP Paribas and CEO of Commodities EMEA of J.P. Morgan, Ms. Flax brings a wealth of experience and knowledge to the Zefiro organization. Named the Most Influential Woman in European...

at 05:20
Hello and welcome to Wisdom Without Borders.   In this series, we will explain the whys, whens and wherefores of classical quotations used by President Xi Jinping. In this episode, we will explain the line, "Think of the...

at 05:05
Mercantile Bank Corporation ("Mercantile") reported net income of $18.8 million, or $1.17 per diluted share, for the second quarter of 2024, compared with net income of $20.4 million, or $1.27 per diluted share, for the second quarter of 2023.  Net...

at 05:00
36Kr Holdings Inc. ("36Kr" or the "Company") , a prominent brand and pioneering platform dedicated to serving New Economy participants in China, today announced that it has entered into a strategic partnership with Zhi-Tech Group ("Zhi-Tech," SZ:...

at 05:00
hedgehog lab, a global digital product consultancy, today announced that it has signed strategic partnerships with Contentful and SHOPLINE. These partnerships aim to empower enterprises to deliver exceptional digital products and...



News published on and distributed by: